Evidence map›Paper›PMID 33732416›Full record

ArticleJournal of extracellular vesicles2021

Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responses.

Marijke I Zonneveld, Martijn J C van Herwijnen, Marcela M Fernandez-Gutierrez, Alberta Giovanazzi, Anne Marit de Groot, Marije Kleinjan, Toni M M van Capel, Alice J A M Sijts, Leonie S Taams, Johan Garssen and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Milk-Derived Extracellular Vesicles and microRNAs: Potential Modulators of Intestinal Homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Marijke I ZonneveldDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Martijn J C van HerwijnenDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Marcela M Fernandez-GutierrezHost-Microbe Interactomics Group Department of Animal Sciences Wageningen University Wageningen The Netherlands.
Alberta GiovanazziDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Anne Marit de GrootDivision of Infectious Diseases & Immunology Department of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Marije KleinjanDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Toni M M van CapelDepartment of Experimental Immunology Academic Medical Center Amsterdam The Netherlands Centre for inflammation University of Amsterdam Amsterdam Infection & Immunity Institute (AI&II) Amsterdam The Netherlands.
Alice J A M SijtsDivision of Infectious Diseases & Immunology Department of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Leonie S TaamsCentre for Inflammation Biology and Cancer Immunology Department of Inflammation Biology School of Immunology & Microbial Sciences King's College London London UK.
Johan GarssenDivision of Pharmacology Department of Pharmaceutical Sciences Faculty of Science Utrecht University Utrecht The Netherlands.
Esther C de JongDepartment of Experimental Immunology Academic Medical Center Amsterdam The Netherlands Centre for inflammation University of Amsterdam Amsterdam Infection & Immunity Institute (AI&II) Amsterdam The Netherlands.
Michiel KleerebezemHost-Microbe Interactomics Group Department of Animal Sciences Wageningen University Wageningen The Netherlands.
Esther N M Nolte-'t HoenDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Frank A RedegeldDivision of Pharmacology Department of Pharmaceutical Sciences Faculty of Science Utrecht University Utrecht The Netherlands.
Marca H M WaubenDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht The Netherlands.
Utrecht University · NLUniversity of Applied Sciences Utrecht · NLAmsterdam Institute for Addiction Research · NLWageningen University & Research · NLKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal milk is nature's first functional food. It plays a crucial role in the development of the infant's gastrointestinal (GI) tract and the immune system. Extracellular vesicles (EVs) are a heterogeneous population of lipid bilayer enclosed vesicles released by cells for intercellular communication and are a component of milk. Recently, we discovered that human milk EVs contain a unique proteome compared to other milk components. Here, we show that physiological concentrations of milk EVs support epithelial barrier function by increasing cell migration via the p38 MAPK pathway. Additionally, milk EVs inhibit agonist-induced activation of endosomal Toll like receptors TLR3 and TLR9. Furthermore, milk EVs directly inhibit activation of CD4+ T cells by temporarily suppressing T cell activation without inducing tolerance. We show that milk EV proteins target key hotspots of signalling networks that can modulate cellular processes in various cell types of the GI tract.

Indexed as

MAP Kinase Signaling SystemAdultCell LineExtracellular VesiclesFemaleHumansMilk, HumanMouth Mucosap38 Mitogen-Activated Protein KinasesT-LymphocytesToll-Like Receptor 3Toll-Like Receptor 9p38 Mitogen-Activated Protein KinasesTLR9 protein, humanToll-Like Receptor 3Toll-Like Receptor 9breast milkexosomesextracellular vesiclesgastrointestinal tracthuman milkimmune modulationimmune system developmentoral cavityT cell modulationTLR modulation

Identifiers

PMID33732416
PMCPMC7944547
OpenAlexW3134363260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.